Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial investigating cannabidiol (CBD) for lower urinary tract dysfunction in spinal cord injury, which is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Supra-sacral Spinal Cord Injury, Spinal Cord Injury | Phase 2 | Status: RECRUITING